Neuroradiolological Analysis of COVID-19 Patients

N/AUnknownNCT04368390

University Hospital, Strasbourg, France100 enrolled

Overview

To describe the radiological presentation of brain abnormalities in COVID-19 + patients

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Covid-19

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults * COVID-19 + * Abnormal neurological examination * who underwent a brain MRI Exclusion Criteria: * No participation agreement * Non COVID-19 patients * Patients COVID-19 + without neurological abnormality or without MRI examination

Locations (1)

Service d'Imagerie 2 - Neuroradiologie

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Neuroradiological analysis of patients brain MRI

Time frame: 1 year

Central Contacts

Stephane Kremer, MD, PhD

CONTACT

33 3 88 12 78 89 stephane.kremer@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

33 3 88 11 66 90 said.chayer@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.